Related Experiment Videos
Are oral hypoglycemic agents likely to benefit NIDDM patients? Affirmative
1Endocrinology Section, State University of New York Health Science Center, Brooklyn.
Hospital Practice (Office Ed.)
|February 1, 1992
Abstract:
The sulfonylureas may prevent progression from impaired glucose tolerance to diabetes as well as control hyperglycemia. Patient response depends on the physiologic status of insulin secretion and effectiveness, however.